Page last updated: 2024-10-17

1-aminocyclopropane-1-carboxylic acid and Spinal Cord Diseases

1-aminocyclopropane-1-carboxylic acid has been researched along with Spinal Cord Diseases in 1 studies

1-aminocyclopropanecarboxylic acid : A non-proteinogenic alpha-amino acid consisting of cyclopropane having amino and carboxy substituents both at the 1-position.

Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.

Research Excerpts

ExcerptRelevanceReference
" These results support earlier indications that: (1) activation of the NMDA receptor complex plays a critical role in mediating dynorphin A-induced rat spinal cord injury; (2) ACPC provides an effective means of antagonizing excitotoxic phenomena; and (3) chronic administration of ACPC can elicit a persistent change in the NMDA receptor complex."1.291-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. ( Long, JB; Skolnick, P, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, JB1
Skolnick, P1

Other Studies

1 other study available for 1-aminocyclopropane-1-carboxylic acid and Spinal Cord Diseases

ArticleYear
1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
    European journal of pharmacology, 1994, Aug-22, Volume: 261, Issue:3

    Topics: Amino Acids; Amino Acids, Cyclic; Animals; Dynorphins; Hindlimb; Injections; Male; Paralysis; Rats;

1994